Cortical Pyramidal Neurone Loss May Cause Glutamatergic Hypoactivity and Cognitive Impairment in Alzheimer's Disease: Investigative and Therapeutic Perspectives

This publication has 147 references indexed in Scilit:

• Animal and drug modelling for Alzheimer synaptic pathology
  Progress in Neurobiology, 1992
• Treatment strategies for Alzheimer's disease
  The Lancet, 1992
• Failure of d-cycloserine to reverse cognitive disruption induced by scopolamine or phencylidine in primates
  Life Sciences, 1992
• Neuropathological stageing of Alzheimer-related changes
  Acta Neuropathologica, 1991
• Glutamate metabotropic and AMPA binding sites are reduced in Alzheimer's disease: an autoradiographic study of the hippocampus
  Brain Research, 1991
• Cognitive and brain imaging measures of Alzheimer's disease
  Neurobiology of Aging, 1988
• Histochemically demonstrable activity of phosphate-activated glutaminase in the postnatally developing rat hippocampus
  Developmental Brain Research, 1988
• On areas of transition between entorhinal allocortex and temporal isocortex in the human brain. Normal morphology and lamina-specific pathology in Alzheimer's disease
  Acta Neuropathologica, 1985
• Neurochemical Studies of Early-Onset Alzheimer's Disease
  New England Journal of Medicine, 1985
• Coenzyme a-acetylating enzymes in Alzheimer's disease: Possible cholinergic ‘compartment’ of pyruvate dehydrogenase
  Neuroscience Letters, 1980